000156531 001__ 156531
000156531 005__ 20251017144553.0
000156531 0247_ $$2doi$$a10.1016/j.jid.2019.05.034
000156531 0248_ $$2sideral$$a117298
000156531 037__ $$aART-2020-117298
000156531 041__ $$aeng
000156531 100__ $$aDalgard, F.J.
000156531 245__ $$aItch and Mental Health in Dermatological Patients across Europe: A Cross-Sectional Study in 13 Countries
000156531 260__ $$c2020
000156531 5060_ $$aAccess copy available to the general public$$fUnrestricted
000156531 5203_ $$aItch is a highly prevalent and multidimensional symptom. We aimed to analyze the association between itch and mental health in dermatological patients. This multicenter study is observational and cross-sectional and was conducted in dermatological clinics across 13 European countries. A total of 3, 530 patients and 1, 094 healthy controls were included. Patients were examined clinically. Outcome measures were itch (presence, chronicity, and intensity), the Hospital Anxiety and Depression Scale, EQ-5D visual analogue scale, sociodemographics, suicidal ideation, and stress (negative life events and economic difficulties). Ethical approval was obtained. Results showed significant association between the presence of itch in patients and clinical depression (odds ratio, 1.53; 95% confidence interval, 1.15–2.02), suicidal ideation (odds ratio, 1.27; 95% confidence interval, 1.01–1.60), and economic difficulties (odds ratio, 1.24; 95% confidence interval, 1.10–1.50). The mean score of reported generic health status assessed by the EQ-5D visual analogue scale was 65.9 (standard deviation = 20.1) in patients with itch, compared with 74.7 (standard deviation = 18.0) in patients without itch (P < 0.001) and 74.9 (standard deviation = 15.7) in controls with itch compared with 82.9 (standard deviation = 15.6) in controls without itch (P < 0.001). Itch contributes substantially to the psychological disease burden in dermatological patients, and the management of patients should include access to multidisciplinary care.
000156531 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc-nd$$uhttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
000156531 590__ $$a8.551$$b2020
000156531 591__ $$aDERMATOLOGY$$b4 / 68 = 0.059$$c2020$$dQ1$$eT1
000156531 592__ $$a1.951$$b2020
000156531 593__ $$aBiochemistry$$c2020$$dQ1
000156531 593__ $$aMolecular Biology$$c2020$$dQ1
000156531 593__ $$aDermatology$$c2020$$dQ1
000156531 593__ $$aCell Biology$$c2020$$dQ1
000156531 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000156531 700__ $$aSvensson, Å.
000156531 700__ $$aHalvorsen, J.A.
000156531 700__ $$aGieler, U.
000156531 700__ $$aSchut, C.
000156531 700__ $$0(orcid)0000-0003-1917-6906$$aTomas-Aragones, L.$$uUniversidad de Zaragoza
000156531 700__ $$aLien, L.
000156531 700__ $$aPoot, F.
000156531 700__ $$aJemec, G.B.E.
000156531 700__ $$aMisery, L.
000156531 700__ $$aSzabo, C.
000156531 700__ $$aLinder, D.
000156531 700__ $$aSampogna, F.
000156531 700__ $$aKoulil, S.S.V.
000156531 700__ $$aBalieva, F.
000156531 700__ $$aSzepietowski, J.C.
000156531 700__ $$aLvov, A.
000156531 700__ $$0(orcid)0000-0001-5632-0351$$aMarron, S.E.$$uUniversidad de Zaragoza
000156531 700__ $$aAltunay, I.K.
000156531 700__ $$aFinlay, A.Y.
000156531 700__ $$aSalek, S.
000156531 700__ $$aKupfer, J.
000156531 7102_ $$14009$$2735$$aUniversidad de Zaragoza$$bDpto. Psicología y Sociología$$cÁrea Psicolog.Evolut.Educac
000156531 7102_ $$11007$$2183$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cÁrea Dermatología
000156531 773__ $$g140, 3 (2020), 568-573$$pJ. invest. dermatol.$$tJOURNAL OF INVESTIGATIVE DERMATOLOGY$$x0022-202X
000156531 8564_ $$s249432$$uhttps://zaguan.unizar.es/record/156531/files/texto_completo.pdf$$yVersión publicada
000156531 8564_ $$s3538217$$uhttps://zaguan.unizar.es/record/156531/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000156531 909CO $$ooai:zaguan.unizar.es:156531$$particulos$$pdriver
000156531 951__ $$a2025-10-17-14:12:18
000156531 980__ $$aARTICLE